0Suppliers
2Customers
3Debt Items
20Related Chains
Precipio, Inc. Suppliers
No suppliers on recordPrecipio, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Precipio, Inc. Customers
| Ticker | Name | Confidence | Evidence |
| ONE-CUSTOMER |
ONE-CUSTOMER |
92%
|
At December 31, 2024, one customer accounted for approximately 29% of our total accounts receivable. |
| THREE-CUSTOMERS |
THREE-CUSTOMERS |
92%
|
At December 31, 2025, we had three customers who each individually represented more than 10% of our total accounts receivable. |
Precipio, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| PRPO-DEBT-11904 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2020-12-31. |
| PRPO-DEBT-11903 |
Warrants outstanding: 10000 |
90%
|
xbrl warrant detail from xbrl 2026-03-31. |
| PRPO-DEBT |
Debt stack $3.7M |
90%
|
Market cache reports total debt of $3.7M. |
Precipio, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Precipio, Inc..
Precipio, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Precipio, Inc..
Precipio, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
| DBVTF |
DBV TECHNOLOGIES |
100.00 |
2 |
|
| BNTC |
Benitec Biopharma Inc. |
100.00 |
2 |
|
| WHWK |
Whitehawk Therapeutics, Inc. |
100.00 |
2 |
|
| BLRX |
BioLineRx Ltd. |
100.00 |
2 |
|
| ALXO |
ALX Oncology Holdings Inc. |
100.00 |
2 |
|
| ATOS |
Atossa Therapeutics, Inc. |
100.00 |
2 |
|
| BNBX |
BNB Plus Corp. |
100.00 |
2 |
|
| CYTOF |
Altamira Therapeutics Ltd. |
100.00 |
2 |
|
| CTMX |
CytomX Therapeutics, Inc. |
100.00 |
2 |
|
| CYTK |
Cytokinetics, Incorporated |
100.00 |
2 |
|
| CBIO |
Crescent Biopharma, Inc. |
100.00 |
2 |
|
| ANL |
Adlai Nortye Ltd. |
100.00 |
2 |
|
| ANRO |
Alto Neuroscience, Inc. |
100.00 |
2 |
|
| EDIT |
Editas Medicine, Inc. |
100.00 |
2 |
|
| CCEP |
Coca-Cola Europacific Partners PLC |
100.00 |
2 |
|
| DSGN |
Design Therapeutics, Inc. |
100.00 |
2 |
|
| PSNL |
Personalis, Inc. |
100.00 |
2 |
|
| AZN |
AstraZeneca PLC |
100.00 |
2 |
|
| BIOA |
BioAge Labs, Inc. |
100.00 |
2 |
|
| REGN |
Regeneron Pharmaceuticals, Inc. |
100.00 |
2 |
|